# AIGH Capital Management LLC

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1835943. Source: https://holderbook.com/funds/1835943-aigh-capital-management-llc/

- Reported value: $1.6B
- Positions: 45
- Weight of the ten largest: 78.0%
- Filed: 2026-08-07

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| SANDISK CORP | [SNDK](https://holderbook.com/stocks/SNDK/) | $338.8M | 149,000 | 21.4% | 4 |
| ISHARES TR | [IWM](https://holderbook.com/stocks/IWM/) | $331.4M | 0 | 20.9% | 2 |
| INVESCO QQQ TR | [QQQ](https://holderbook.com/stocks/QQQ/) | $141.8M | 0 | 8.9% | 1 |
| MAXLINEAR INC | [MXL](https://holderbook.com/stocks/MXL/) | $104.7M | 818,000 | 6.6% | 1 |
| INTEL CORP | [INTC](https://holderbook.com/stocks/INTC/) | $87.1M | 623,500 | 5.5% | 1 |
| DIGITAL TURBINE INC | [APPS](https://holderbook.com/stocks/APPS/) | $84.5M | 6,548,450 | 5.3% | 2 |
| SILICON MOTION TECHNOLOGY CO | [SIMO](https://holderbook.com/stocks/SIMO/) | $48.0M | 144,000 | 3.0% | 2 |
| CLEARFIELD INC | [CLFD](https://holderbook.com/stocks/CLFD/) | $40.1M | 1,008,469 | 2.5% | 1 |
| METHODE ELECTRS INC | [MEI](https://holderbook.com/stocks/MEI/) | $31.8M | 1,678,409 | 2.0% | 1 |
| AMTECH SYS INC | [ASYS](https://holderbook.com/stocks/ASYS/) | $28.9M | 1,252,000 | 1.8% | 1 |
| FENNEC PHARMACEUTICALS INC | [FENC](https://holderbook.com/stocks/FENC/) | $26.7M | 2,486,038 | 1.7% | 6 |
| KYVERNA THERAPEUTICS INC | [KYTX](https://holderbook.com/stocks/KYTX/) | $24.9M | 2,795,797 | 1.6% | 3 |
| NYXOAH S A | [NYXH](https://holderbook.com/stocks/NYXH/) | $24.6M | 14,534,880 | 1.5% | 1 |
| PERSONALIS INC | [PSNL](https://holderbook.com/stocks/PSNL/) | $23.0M | 1,715,000 | 1.4% | 8 |
| SOPHIA GENETICS SA | [SOPH](https://holderbook.com/stocks/SOPH/) | $22.8M | 3,954,194 | 1.4% | 1 |
| 3-D SYS CORP DEL | [DDD](https://holderbook.com/stocks/DDD/) | $22.0M | 7,271,000 | 1.4% | 1 |
| VUZIX CORP | [VUZI](https://holderbook.com/stocks/VUZI/) | $19.6M | 6,745,667 | 1.2% | 2 |
| ABEONA THERAPEUTICS INC | [ABEO](https://holderbook.com/stocks/ABEO/) | $18.5M | 2,987,000 | 1.2% | 3 |
| ARDELYX INC | [ARDX](https://holderbook.com/stocks/ARDX/) | $16.3M | 3,200,000 | 1.0% | 1 |
| BIODESIX INC | [BDSX](https://holderbook.com/stocks/BDSX/) | $15.3M | 678,328 | 1.0% | 2 |
| SPRUCE BIOSCIENCES INC | [SPRB](https://holderbook.com/stocks/SPRB/) | $13.5M | 250,000 | 0.9% | 1 |
| CASTLE BIOSCIENCES INC | [CSTL](https://holderbook.com/stocks/CSTL/) | $13.0M | 545,101 | 0.8% | 4 |
| VANDA PHARMACEUTICALS INC | [VNDA](https://holderbook.com/stocks/VNDA/) | $12.5M | 2,044,169 | 0.8% | 3 |
| PELTHOS THERAPEUTICS INC | [PTHS](https://holderbook.com/stocks/PTHS/) | $9.3M | 329,098 | 0.6% | 1 |
| DOMO INC | [DOMO](https://holderbook.com/stocks/DOMO/) | $9.0M | 0 | 0.6% | 1 |
| POLYPID LTD | [PYPD](https://holderbook.com/stocks/PYPD/) | $7.6M | 1,504,741 | 0.5% | 10 |
| VERASTEM INC | [VSTM](https://holderbook.com/stocks/VSTM/) | $7.4M | 1,927,000 | 0.5% | 2 |
| BROADWIND INC | [BWEN](https://holderbook.com/stocks/BWEN/) | $5.6M | 1,156,000 | 0.4% | 1 |
| AEYE INC | [LIDR](https://holderbook.com/stocks/LIDR/) | $5.6M | 3,855,000 | 0.3% | 1 |
| ORTHOPEDIATRICS CORP | [KIDS](https://holderbook.com/stocks/KIDS/) | $5.2M | 269,765 | 0.3% | 1 |
| APYX MEDICAL CORPORATION | [APYX](https://holderbook.com/stocks/APYX/) | $5.1M | 1,128,343 | 0.3% | 3 |
| IDEAL PWR INC | [IPWR](https://holderbook.com/stocks/IPWR/) | $4.8M | 894,731 | 0.3% | 21 |
| TALPHERA INC | [TLPH](https://holderbook.com/stocks/TLPH/) | $4.7M | 4,601,502 | 0.3% | 4 |
| TIGO ENERGY INC | [TYGO](https://holderbook.com/stocks/TYGO/) | $4.6M | 1,990,371 | 0.3% | 2 |
| ENERGOUS CORP | [WATT](https://holderbook.com/stocks/WATT/) | $4.4M | 182,000 | 0.3% | 2 |
| RENOVORX INC | [RNXT](https://holderbook.com/stocks/RNXT/) | $4.3M | 4,405,439 | 0.3% | 6 |
| RICHARDSON ELECTRS LTD | [RELL](https://holderbook.com/stocks/RELL/) | $3.8M | 200,434 | 0.2% | 1 |
| NEURAXIS INC | [NRXS](https://holderbook.com/stocks/NRXS/) | $3.8M | 519,938 | 0.2% | 6 |
| COYA THERAPEUTICS INC | [COYA](https://holderbook.com/stocks/COYA/) | $3.7M | 631,912 | 0.2% | 15 |
| IDENTIV INC | [INVE](https://holderbook.com/stocks/INVE/) | $3.7M | 1,449,121 | 0.2% | 2 |
| ELUTIA INC | [ELUT](https://holderbook.com/stocks/ELUT/) | $2.6M | 2,695,644 | 0.2% | 12 |
| APREA THERAPEUTICS INC | [APRE](https://holderbook.com/stocks/APRE/) | $814.8K | 1,015,541 | 0.1% | 14 |
| BIOFRONTERA INC | [BFRI](https://holderbook.com/stocks/BFRI/) | $699.6K | 739,910 | 0.0% | 10 |
| QUOIN PHARMACEUTICALS LTD | [QNRX](https://holderbook.com/stocks/QNRX/) | $338.8K | 70,000 | 0.0% | 3 |
| NN INC | [NNBR](https://holderbook.com/stocks/NNBR/) | $41.3K | 11,496 | 0.0% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +97.8% | +14.8% | +83.0% | 100% |
| Q1 2026 | +31.8% | -4.6% | +36.4% | 100% |
| Q4 2025 | +24.3% | +2.4% | +21.9% | 97% |
| Q3 2025 | +26.7% | +7.8% | +18.9% | 100% |
| Q2 2025 | +19.0% | +10.5% | +8.6% | 100% |
| Q1 2025 | -20.2% | -4.6% | -15.7% | 83% |
| Q4 2024 | +8.6% | +2.1% | +6.5% | 87% |
| Q3 2024 | -1.5% | +5.4% | -6.9% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $1.6B | 45 |
| Q1 2026 | $733.2M | 43 |
| Q4 2025 | $413.1M | 34 |
| Q3 2025 | $354.9M | 37 |
| Q2 2025 | $222.3M | 35 |
| Q1 2025 | $241.6M | 41 |
| Q4 2024 | $319.8M | 36 |
| Q3 2024 | $354.6M | 39 |
| Q2 2024 | $321.0M | 38 |
| Q1 2024 | $333.0M | 43 |
| Q4 2023 | $252.8M | 39 |
| Q3 2023 | $211.3M | 48 |